Morningstar, Inc. logo MORN - Morningstar, Inc.

Price: -- -- | CONSENSUS: Hold DETAILS
STRONG
BUY
0
BUY 2
HOLD 4
SELL 0
STRONG
SELL
0
| PRICE TARGET: $236.50 DETAILS
HIGH: $280.00
LOW: $193.00
MEDIAN: $236.50
CONSENSUS: $236.50
UPSIDE: 31.65%
AlphaVal

AlphaVal

Deterministic, archetype-aware fair value

Banks, Insurers & Asset Managers 80% confidence

Primary model: P/Tangible Book × ROE Quality

Valuation Signal Overvalued Moderate
Trading 19.7% above fair value
Current Price $179.64
Bear Case $105.03 41.5% downside ($105.03 - $179.64) / $179.64 = -41.5% ROTCE 20.0% → 2.80x TBV
Fair Value $150.12 16.4% downside ($150.12 - $179.64) / $179.64 = -16.4% ROTCE 25.0% → 4.00x TBV
Bull Case $150.12 16.4% downside ($150.12 - $179.64) / $179.64 = -16.4% ROTCE 30.0% → 4.00x TBV

Adjust Assumptions

30.6%
9.7%

Key Value Driver

ROTCE (30.6%) vs. cost of equity (9.7%)

Implied Market Multiple 5.59x

Plain-Language Summary

Our base-case estimate uses P/Tangible Book × ROE Quality. We then blend that result with the average analyst price target of $236.50 from 6 analysts, using a 20% weight on analyst consensus. That produces an estimated intrinsic value of $150.12 per share.

Warnings

Traditional cash flow models don't work well for banks — lending activity distorts how much cash the business actually generates.
Common valuation shortcuts don't apply here — for banks, interest payments are a core business cost, not overhead.
Dividend-based valuation: $72.97 (43% below our primary estimate). Large gaps suggest the dividend may not fully reflect the company's value.
Wall Street's average price target is $236.50 (from 6 analysts). Our estimate is 46% below the consensus -- consider that gap carefully.

Key Risks

  • Book value quality matters as much as level — check loan loss reserves
  • Interest rate sensitivity creates non-linear earnings surprises
  • Insurance reserving is actuarial, not financial — errors emerge slowly